norethindrone and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

norethindrone has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mueck, AO; Seeger, H; Wallwiener, D	1

Other Studies

1 other study(ies) available for norethindrone and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

Article	Year
Additive antioxidative effect of hormone replacement therapy combined with a statin. Clinical and experimental obstetrics & gynecology, 2000, Volume: 27, Issue:3-4 Topics: Anticholesteremic Agents; Antioxidants; Arteriosclerosis; Drug Interactions; Estradiol; Estrogen Replacement Therapy; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipid Peroxidation; Lipoproteins, LDL; Norethindrone; Norethindrone Acetate; Postmenopause	2000

Article

Year

Additive antioxidative effect of hormone replacement therapy combined with a statin.

Clinical and experimental obstetrics & gynecology, 2000, Volume: 27, Issue:3-4

Topics: Anticholesteremic Agents; Antioxidants; Arteriosclerosis; Drug Interactions; Estradiol; Estrogen Replacement Therapy; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipid Peroxidation; Lipoproteins, LDL; Norethindrone; Norethindrone Acetate; Postmenopause

2000